The benefits of coronavirus suppression: A cost-benefit analysis of the response to the first wave of COVID-19 in the United States

This paper estimates the benefits and costs of state suppression policies to "bend the curve" during the initial outbreak of COVID-19 in the United States. We employ an approach that values benefits and costs in terms of additions or subtractions to total production. Relative to a baseline...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2021-06, Vol.16 (6), p.e0252729-e0252729
Main Authors: Broughel, James, Kotrous, Michael
Format: Article
Language:English
Subjects:
Benefit cost analysis
Biology and Life Sciences
Commerce - economics
Coronaviruses
Cost benefit analysis
Cost control
Cost-Benefit Analysis - methods
COVID-19
COVID-19 - economics
Disease control
Disease transmission
Educational facilities
Enforcement
Evaluation
GDP
Gross Domestic Product
Health promotion
Health risks
Human capital
Humans
Medicine and Health Sciences
Mortality
Opportunity costs
Pandemics
People and Places
Physical Distancing
Population
Public health
Quarantine - economics
SARS-CoV-2 - pathogenicity
Shelter in place
Social distancing
United States
Viral diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c758t-b12b7bd868b31818ad325de7fd9866cb230b7bce8230c325177203216547cbd53
cites cdi_FETCH-LOGICAL-c758t-b12b7bd868b31818ad325de7fd9866cb230b7bce8230c325177203216547cbd53
container_end_page e0252729
container_issue 6
container_start_page e0252729
container_title PloS one
container_volume 16
creator Broughel, James
Kotrous, Michael
description This paper estimates the benefits and costs of state suppression policies to "bend the curve" during the initial outbreak of COVID-19 in the United States. We employ an approach that values benefits and costs in terms of additions or subtractions to total production. Relative to a baseline in which only the infected and at-risk populations mitigate the spread of coronavirus, we estimate that total benefits of suppression policies to economic output are between $632.5 billion and $765.0 billion from early March 2020 to August 1, 2020. Relative to private mitigation, output lost due to suppression policies is estimated to be between $214.2 billion and $331.5 billion. The cost estimate is based on the duration of nonessential business closures and stay-at-home orders, which were enforced between 42 and 65 days. Our results indicate that the net benefits of suppression policies to slow the spread of COVID-19 are positive and may be substantial. We discuss uncertainty surrounding several parameters and employ alternative methods for valuing mortality benefits, which also suggest that suppression measures had positive net benefits.
doi_str_mv 10.1371/journal.pone.0252729
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2536796600</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A663983582</galeid><doaj_id>oai_doaj_org_article_ede58ac22669494ea1b8910b545ba534</doaj_id><sourcerecordid>A663983582</sourcerecordid><originalsourceid>FETCH-LOGICAL-c758t-b12b7bd868b31818ad325de7fd9866cb230b7bce8230c325177203216547cbd53</originalsourceid><addsrcrecordid>eNqNk02P0zAQhiMEYpfCP0AQCQnBoSWOYzvhgFSVr0orVWI_rpbjTFpXaVxsp7Bn_jiTNrtq0R6QD3E8z7zjmfFE0UuSTAgV5MPadq5VzWRrW5gkKUtFWjyKzklB0zFPE_r4aH8WPfN-nSSM5pw_jc5oluREMHEe_blaQVxCC7UJPrZ1rK2zrdoZ1_nYd9utA--NbT_GUzT5MB7YWGHsW2_2PgE1kMObeIiD3f_XxvkQ_1I76InZ4mb-eUyK2LR763VrAlTxZVAB_PPoSa0aDy-G7yi6_vrlavZ9fLH4Np9NL8ZasBwjk7QUZZXzvKQkJ7mqaMoqEHVVYFa6TGmCdg05bjSaiBCYeko4y4QuK0ZH0euD7raxXg718zJllIuC8yRBYn4gKqvWcuvMRrlbaZWR-wPrllK5YHQDEipgudJpynmRFRkoUuYFSUqWsVIxmqHWpyFaV26g0tAGp5oT0VNLa1ZyaXcSO5MJ0gu8GwSc_dmBD3JjvIamUS3Ybn9vwSnFPiL65h_04ewGaqkwAdPWFuPqXlROOadFThnWbhRNHqBwVbAx2vbdx_MTh_cnDsgE-B2WqvNezi9__D-7uDll3x6xK1BNWHnbdAGfoz8FswOonfXeQX1fZJLIflbuqiH7WZHDrKDbq-MG3TvdDQf9C4Q0DfU</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2536796600</pqid></control><display><type>article</type><title>The benefits of coronavirus suppression: A cost-benefit analysis of the response to the first wave of COVID-19 in the United States</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><creator>Broughel, James ; Kotrous, Michael</creator><contributor>Horton, Susan</contributor><creatorcontrib>Broughel, James ; Kotrous, Michael ; Horton, Susan</creatorcontrib><description>This paper estimates the benefits and costs of state suppression policies to "bend the curve" during the initial outbreak of COVID-19 in the United States. We employ an approach that values benefits and costs in terms of additions or subtractions to total production. Relative to a baseline in which only the infected and at-risk populations mitigate the spread of coronavirus, we estimate that total benefits of suppression policies to economic output are between $632.5 billion and $765.0 billion from early March 2020 to August 1, 2020. Relative to private mitigation, output lost due to suppression policies is estimated to be between $214.2 billion and $331.5 billion. The cost estimate is based on the duration of nonessential business closures and stay-at-home orders, which were enforced between 42 and 65 days. Our results indicate that the net benefits of suppression policies to slow the spread of COVID-19 are positive and may be substantial. We discuss uncertainty surrounding several parameters and employ alternative methods for valuing mortality benefits, which also suggest that suppression measures had positive net benefits.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0252729</identifier><identifier>PMID: 34081757</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Benefit cost analysis ; Biology and Life Sciences ; Commerce - economics ; Coronaviruses ; Cost benefit analysis ; Cost control ; Cost-Benefit Analysis - methods ; COVID-19 ; COVID-19 - economics ; Disease control ; Disease transmission ; Educational facilities ; Enforcement ; Evaluation ; GDP ; Gross Domestic Product ; Health promotion ; Health risks ; Human capital ; Humans ; Medicine and Health Sciences ; Mortality ; Opportunity costs ; Pandemics ; People and Places ; Physical Distancing ; Population ; Public health ; Quarantine - economics ; SARS-CoV-2 - pathogenicity ; Shelter in place ; Social distancing ; United States ; Viral diseases</subject><ispartof>PloS one, 2021-06, Vol.16 (6), p.e0252729-e0252729</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><rights>2021 Broughel, Kotrous. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Broughel, Kotrous 2021 Broughel, Kotrous</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c758t-b12b7bd868b31818ad325de7fd9866cb230b7bce8230c325177203216547cbd53</citedby><cites>FETCH-LOGICAL-c758t-b12b7bd868b31818ad325de7fd9866cb230b7bce8230c325177203216547cbd53</cites><orcidid>0000-0002-2586-9082</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2536796600/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2536796600?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34081757$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Horton, Susan</contributor><creatorcontrib>Broughel, James</creatorcontrib><creatorcontrib>Kotrous, Michael</creatorcontrib><title>The benefits of coronavirus suppression: A cost-benefit analysis of the response to the first wave of COVID-19 in the United States</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>This paper estimates the benefits and costs of state suppression policies to "bend the curve" during the initial outbreak of COVID-19 in the United States. We employ an approach that values benefits and costs in terms of additions or subtractions to total production. Relative to a baseline in which only the infected and at-risk populations mitigate the spread of coronavirus, we estimate that total benefits of suppression policies to economic output are between $632.5 billion and $765.0 billion from early March 2020 to August 1, 2020. Relative to private mitigation, output lost due to suppression policies is estimated to be between $214.2 billion and $331.5 billion. The cost estimate is based on the duration of nonessential business closures and stay-at-home orders, which were enforced between 42 and 65 days. Our results indicate that the net benefits of suppression policies to slow the spread of COVID-19 are positive and may be substantial. We discuss uncertainty surrounding several parameters and employ alternative methods for valuing mortality benefits, which also suggest that suppression measures had positive net benefits.</description><subject>Benefit cost analysis</subject><subject>Biology and Life Sciences</subject><subject>Commerce - economics</subject><subject>Coronaviruses</subject><subject>Cost benefit analysis</subject><subject>Cost control</subject><subject>Cost-Benefit Analysis - methods</subject><subject>COVID-19</subject><subject>COVID-19 - economics</subject><subject>Disease control</subject><subject>Disease transmission</subject><subject>Educational facilities</subject><subject>Enforcement</subject><subject>Evaluation</subject><subject>GDP</subject><subject>Gross Domestic Product</subject><subject>Health promotion</subject><subject>Health risks</subject><subject>Human capital</subject><subject>Humans</subject><subject>Medicine and Health Sciences</subject><subject>Mortality</subject><subject>Opportunity costs</subject><subject>Pandemics</subject><subject>People and Places</subject><subject>Physical Distancing</subject><subject>Population</subject><subject>Public health</subject><subject>Quarantine - economics</subject><subject>SARS-CoV-2 - pathogenicity</subject><subject>Shelter in place</subject><subject>Social distancing</subject><subject>United States</subject><subject>Viral diseases</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNk02P0zAQhiMEYpfCP0AQCQnBoSWOYzvhgFSVr0orVWI_rpbjTFpXaVxsp7Bn_jiTNrtq0R6QD3E8z7zjmfFE0UuSTAgV5MPadq5VzWRrW5gkKUtFWjyKzklB0zFPE_r4aH8WPfN-nSSM5pw_jc5oluREMHEe_blaQVxCC7UJPrZ1rK2zrdoZ1_nYd9utA--NbT_GUzT5MB7YWGHsW2_2PgE1kMObeIiD3f_XxvkQ_1I76InZ4mb-eUyK2LR763VrAlTxZVAB_PPoSa0aDy-G7yi6_vrlavZ9fLH4Np9NL8ZasBwjk7QUZZXzvKQkJ7mqaMoqEHVVYFa6TGmCdg05bjSaiBCYeko4y4QuK0ZH0euD7raxXg718zJllIuC8yRBYn4gKqvWcuvMRrlbaZWR-wPrllK5YHQDEipgudJpynmRFRkoUuYFSUqWsVIxmqHWpyFaV26g0tAGp5oT0VNLa1ZyaXcSO5MJ0gu8GwSc_dmBD3JjvIamUS3Ybn9vwSnFPiL65h_04ewGaqkwAdPWFuPqXlROOadFThnWbhRNHqBwVbAx2vbdx_MTh_cnDsgE-B2WqvNezi9__D-7uDll3x6xK1BNWHnbdAGfoz8FswOonfXeQX1fZJLIflbuqiH7WZHDrKDbq-MG3TvdDQf9C4Q0DfU</recordid><startdate>20210603</startdate><enddate>20210603</enddate><creator>Broughel, James</creator><creator>Kotrous, Michael</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2586-9082</orcidid></search><sort><creationdate>20210603</creationdate><title>The benefits of coronavirus suppression: A cost-benefit analysis of the response to the first wave of COVID-19 in the United States</title><author>Broughel, James ; Kotrous, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c758t-b12b7bd868b31818ad325de7fd9866cb230b7bce8230c325177203216547cbd53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Benefit cost analysis</topic><topic>Biology and Life Sciences</topic><topic>Commerce - economics</topic><topic>Coronaviruses</topic><topic>Cost benefit analysis</topic><topic>Cost control</topic><topic>Cost-Benefit Analysis - methods</topic><topic>COVID-19</topic><topic>COVID-19 - economics</topic><topic>Disease control</topic><topic>Disease transmission</topic><topic>Educational facilities</topic><topic>Enforcement</topic><topic>Evaluation</topic><topic>GDP</topic><topic>Gross Domestic Product</topic><topic>Health promotion</topic><topic>Health risks</topic><topic>Human capital</topic><topic>Humans</topic><topic>Medicine and Health Sciences</topic><topic>Mortality</topic><topic>Opportunity costs</topic><topic>Pandemics</topic><topic>People and Places</topic><topic>Physical Distancing</topic><topic>Population</topic><topic>Public health</topic><topic>Quarantine - economics</topic><topic>SARS-CoV-2 - pathogenicity</topic><topic>Shelter in place</topic><topic>Social distancing</topic><topic>United States</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Broughel, James</creatorcontrib><creatorcontrib>Kotrous, Michael</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>https://resources.nclive.org/materials</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials science collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Broughel, James</au><au>Kotrous, Michael</au><au>Horton, Susan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The benefits of coronavirus suppression: A cost-benefit analysis of the response to the first wave of COVID-19 in the United States</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2021-06-03</date><risdate>2021</risdate><volume>16</volume><issue>6</issue><spage>e0252729</spage><epage>e0252729</epage><pages>e0252729-e0252729</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>This paper estimates the benefits and costs of state suppression policies to "bend the curve" during the initial outbreak of COVID-19 in the United States. We employ an approach that values benefits and costs in terms of additions or subtractions to total production. Relative to a baseline in which only the infected and at-risk populations mitigate the spread of coronavirus, we estimate that total benefits of suppression policies to economic output are between $632.5 billion and $765.0 billion from early March 2020 to August 1, 2020. Relative to private mitigation, output lost due to suppression policies is estimated to be between $214.2 billion and $331.5 billion. The cost estimate is based on the duration of nonessential business closures and stay-at-home orders, which were enforced between 42 and 65 days. Our results indicate that the net benefits of suppression policies to slow the spread of COVID-19 are positive and may be substantial. We discuss uncertainty surrounding several parameters and employ alternative methods for valuing mortality benefits, which also suggest that suppression measures had positive net benefits.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>34081757</pmid><doi>10.1371/journal.pone.0252729</doi><tpages>e0252729</tpages><orcidid>https://orcid.org/0000-0002-2586-9082</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2021-06, Vol.16 (6), p.e0252729-e0252729
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2536796600
source PubMed (Medline); Publicly Available Content Database
subjects Benefit cost analysis
Biology and Life Sciences
Commerce - economics
Coronaviruses
Cost benefit analysis
Cost control
Cost-Benefit Analysis - methods
COVID-19
COVID-19 - economics
Disease control
Disease transmission
Educational facilities
Enforcement
Evaluation
GDP
Gross Domestic Product
Health promotion
Health risks
Human capital
Humans
Medicine and Health Sciences
Mortality
Opportunity costs
Pandemics
People and Places
Physical Distancing
Population
Public health
Quarantine - economics
SARS-CoV-2 - pathogenicity
Shelter in place
Social distancing
United States
Viral diseases
title The benefits of coronavirus suppression: A cost-benefit analysis of the response to the first wave of COVID-19 in the United States
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T07%3A18%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20benefits%20of%20coronavirus%20suppression:%20A%20cost-benefit%20analysis%20of%20the%20response%20to%20the%20first%20wave%20of%20COVID-19%20in%20the%20United%20States&rft.jtitle=PloS%20one&rft.au=Broughel,%20James&rft.date=2021-06-03&rft.volume=16&rft.issue=6&rft.spage=e0252729&rft.epage=e0252729&rft.pages=e0252729-e0252729&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0252729&rft_dat=%3Cgale_plos_%3EA663983582%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c758t-b12b7bd868b31818ad325de7fd9866cb230b7bce8230c325177203216547cbd53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2536796600&rft_id=info:pmid/34081757&rft_galeid=A663983582&rfr_iscdi=true